Evidence map›Paper›PMID 36404408›Full record

ArticleThoracic cancer2023

Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report.

Kei Kunimasa, Takako Inoue, Yugo Kai, Ryu Kanzaki, Sachi Kawagishi, Ken-Ichi Yoshida, Keiichiro Honma, Motohiro Tamiya, Takahisa Kawamura, Kazumi Nishino

Abstract readCase Reports
In one paragraph

Article in Thoracic cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kei KunimasaDepartment of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.ORCID 0000-0002-5241-3486
Takako InoueDepartment of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Yugo KaiDepartment of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Ryu KanzakiDepartment of General Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan.
Sachi KawagishiDepartment of General Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan.
Ken-Ichi YoshidaDepartment of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
Keiichiro HonmaDepartment of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
Motohiro TamiyaDepartment of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Takahisa KawamuraDepartment of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Kazumi NishinoDepartment of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid and reliable identification of targetable driver mutations in patients with advanced stage lung cancer is essential. Adequate amount of tumor tissue biopsies (i.e., genomic biopsies) are required to successfully analyze the gene panel. In the present case, we performed three pleural fluid investigations, including transbronchial biopsy of the primary tumor, transesophageal endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of lymph node metastasis, and thoracoscopic biopsy of the pleural seeding sites. Among the three investigations, thoracoscopic biopsy alone successfully obtained a sufficient amount of tissue. Thus, it is important to determine the technique and site of biopsy, as multiple biopsies are not only burdensome to the patient, but also lead to significant delays in therapy induction.

Indexed as

EndosonographyLung NeoplasmsEndoscopic Ultrasound-Guided Fine Needle AspirationHumansLymphatic Metastasisgene panelgenomic biopsylung cancerrapid on-site evaluationthoracoscopy

Identifiers

PMID36404408
PMCPMC9807439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.